Financhill
Back

KraneShares Emerging Markets Consumer Tech Idx ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Buy
54

KEMQ
KraneShares Emerging Markets Consumer Tech Idx ETF

Last Price:
$25.25
Seasonality Move:
-0.05%
Buy
64

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$90.20
Seasonality Move:
-30.03%
Buy
54
KraneShares Emerging Markets Consumer Tech Idx ETF (KEMQ) is a Buy

Is KraneShares Emerging Markets Consumer Tech Idx ETF a Buy, Sell or Hold?

  • The current KraneShares Emerging Markets Consumer Tech Idx ETF [KEMQ] share price is $25.13. The Score for KEMQ is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • KEMQ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $93.99. The Score for DRUG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KEMQ Stock Price Chart

What is KraneShares Emerging Markets Consumer Tech Idx ETF's stock price today?

  • The KraneShares Emerging Markets Consumer Tech Idx ETF share price today is $25.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KEMQ is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $93.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

KEMQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 38.56 Sell
Chaikin Money Flow: 5398 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.78 Buy
Relative Strength Index (14 RSI): 76.13 Buy
Chaikin Money Flow: 147064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.66 - 81.44) Buy
Bollinger Bands (100): (40.97 - 68.09) Buy

KEMQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.7 Sell
20-day SMA: 25.62 Sell
50-day SMA: 26.16 Sell
200-day SMA: 22.69 Buy
8-day EMA: 25.55 Sell
20-day EMA: 25.75 Sell
50-day EMA: 25.36 Sell
200-day EMA: 15.95 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.53 Buy
20-day SMA: 72.88 Buy
50-day SMA: 64.83 Buy
200-day SMA: 42.54 Buy
8-day EMA: 84.37 Buy
20-day EMA: 75.93 Buy
50-day EMA: 66.06 Buy
200-day EMA: 46.89 Buy

KraneShares Emerging Markets Consumer Tech Idx ETF Earnings Growth & KEMQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

KraneShares Emerging Markets Consumer Tech Idx ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):